NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . July 27th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

Angiogenesis - Scientists at Third Military Medical University discuss research in angiogenesis

Angiotensins - Exforge HCT® the only 3-in-1 single pill high blood pressure therapy shown more effective than dual combinations of its components

Cancer Vaccines - Research from University of Zurich in the area of cancer vaccines published

Cancer Vaccines - Research results from Medical University of Vienna update knowledge of cancer vaccines

Thrombosis - Investigators at Stanford University zero in on thrombosis

Cancer Vaccines - Chulalongkorn University, Department of Pediatrics details research in cancer vaccines

Cancer Vaccines - ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens

Exocrine Pancreatic Insufficiency - Solvay Pharmaceuticals, Inc. Announces Commercial Availability of CREON(R) (Pancrelipase) Delayed-Release Capsules First and only FDA-approved therapy for exocrine pancreatic insuf

ImmunoCellular Therapeutics, Ltd. - ImmunoCellular Therapeutics Retains Services of Torrey Pines Institute for Molecular Studies and Renowned Immunologist to Evaluate Lead Product Candidate

Influenza - St. Jude Virologist Honored by the Royal Society



Return to Top of Page

-----------------------
PR Login